Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution
M. Boulanger, Emily Molina, Kunbo Wang, Thomas S. Kickler, Yanxun Xu, Brian T. Garibaldi
Topics & Concepts
MedicineDiseaseHazard ratioInternal medicineCoronavirusImmunologyConfidence intervalCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations